Targeted Alpha Therapy (TAT) has emerged as one of the most powerful cancer treatment available thanks to its ability to cause large amounts of damage near a tumor cell while keeping the healthy surrounding tissue intact.
Our mission is to support the U.S. Department of Energy Isotope Program as the global leader in the production and distribution of radioactive and enriched stable isotopes that are deemed critical or are in short supply.